Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FLXN

Flexion Therapeutics (FLXN) Stock Price, News & Analysis

Flexion Therapeutics logo

About Flexion Therapeutics Stock (NASDAQ:FLXN)

Advanced Chart

Key Stats

Today's Range
$25.08
$25.08
50-Day Range
$9.12
$9.44
52-Week Range
$4.30
$13.66
Volume
2 shs
Average Volume
1.18 million shs
Market Capitalization
$1.26 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FLXN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Flexion Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FLXN Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
VIRI Virios Therapeutics, Inc.
Spyre Therapeutics Inc SYRE
PFIZER INC's Net Worth
See More Headlines

FLXN Stock Analysis - Frequently Asked Questions

Flexion Therapeutics, Inc. (NASDAQ:FLXN) issued its quarterly earnings data on Wednesday, May, 12th. The specialty pharmaceutical company reported ($0.57) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.49) by $0.08. The specialty pharmaceutical company earned $24.59 million during the quarter, compared to analyst estimates of $24.61 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Flexion Therapeutics investors own include Regulus Therapeutics (RGLS), NVIDIA (NVDA), Gilead Sciences (GILD), Bristol Myers Squibb (BMY), Lipocine (LPCN), Micron Technology (MU) and Viking Therapeutics (VKTX).

Company Calendar

Last Earnings
5/12/2021
Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FLXN
Employees
257
Year Founded
2007

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$113.71 million
Net Margins
-100.32%
Pretax Margin
-100.32%

Debt

Sales & Book Value

Annual Sales
$85.55 million
Price / Cash Flow
N/A
Book Value
($0.34) per share
Price / Book
-73.76

Miscellaneous

Free Float
45,727,000
Market Cap
$1.26 billion
Optionable
No Data
Beta
1.53

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:FLXN) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners